ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1913

Inter-Omic Analysis Reveals Functional Relationship between Diverse Gut Microbiota and Dysregulated Host Immune Response in HLA-B27-Mediated Experimental Spondyloarthritis

Tejpal Gill1, Stephen R. Brooks2, Mark Asquith3, James T. Rosenbaum4 and Robert Colbert5, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2Biodata Mining and Discovery Section, Office of Science and Technology, NIAMS/NIH, Bethesda, MD, 3Oregon Health & Science University, Portland, OR, 4Ophthalmology, Oregon Health & Science University and Legacy Devers Eye Institute, Portland, OR, 5NIAMS/NIH, Bethesda, MD

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Arthritis, inflammatory bowel disease (IBD) and microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: HLA-B27 has been hypothesized to alter gut microbiota and host-microbe interactions to promote spondyloarthritis (SpA). In HLA-B27 transgenic (HLA-B27 Tg) rats with experimental SpA, we have reported that HLA-B27 effects on gut microbiota diverge on different genetic backgrounds despite common patterns of immune dysregulation. Using an integrative analysis of gut microbiome and host transcriptome (inter-omics), we asked which microbes correlate with immune dysregulation on different genetic backgrounds, and whether they have similar functional implications.

Methods: We correlated the relative frequency of gut microbes determined by 16S rRNA gene sequencing, with host gene expression determined by RNAseq, for cecum and colon samples derived from 193 HLA-B27 Tg and wild type (WT) rats from Dark Agouti (DA), Lewis (LEW) and Fischer (F344) backgrounds. Microbes with a relative abundance of >0.1% in at least one sample, and genes with expression values (reads per kilobase million; RPKM) >1 in at least one sample and a coefficient of variation >0.8 across the dataset were included. Significant correlation coefficients (r) between the microbial relative frequency and transcript RPKM value (p<0.05) were used to identify relevant relationships. PICRUSt was used to predict microbial functions based on metagenomic profiles, which were then correlated with disease severity (histology scores), and significant metabolic pertubations associated with inflammation were identified (q<0.05 based on FDR-corrected p-values was used).

Results: Inter-omic analysis revealed several microbes associated with dysregulated cytokines driving inflammatory response pathways (e.g. IL-23, IL-17, IL-12, IFN-g, TNF) in both cecum and colon. While some microbes were differentially abundant on both LEW and F344 backgrounds (Clostridium, Ruminococcus), other differences were unique to either LEW (Prevotella, Dehalobacterium, Sutterella) or F344 (Akkermansia, rc4-4, Coprococcus, Blautia). Interestingly, many microbes that were strongly correlated with immune dysregulation (e.g. Granulicatella, Staphylococcus and members of family Lachnospiraceae) were not identified by analyzing effects of HLA-B27 alone. Metabolic functions of microbes determined by PICRUSt revealed involvement of similar pathways (e.g. fatty acid and glycan biosynthesis, steroid biosynthesis) in both HLA-B27 Tg LEW and HLA-B27 Tg F344 rats, despite dramatic differences in microbial dysbiosis.

Conclusion: Inter-omic anaylsis of gut microbiota and the host immune response in experimental SpA provides an unprecedented view of the complexity of microbial dysbiosis associated with HLA-B27 and gut inflammation. Perturbation of common metabolic pathways by divergent gut microbiota on different genetic backgrounds during inflammation suggests important functional overlaps that may be key to evoking similar host immune dysregulation. These results suggest that effects of HLA-B27 in the human population will depend on other genetic factors, and that microbial communities and their function may be more important than individual microbes.


Disclosure: T. Gill, None; S. R. Brooks, None; M. Asquith, None; J. T. Rosenbaum, AbbVie, UCB, XOMA, Santen, Novartis, Gilead, Mallinkrodt, Eyevensys, Theravance, Cavtherx, Portage, Topivert, Regeneron, Allergan, and Sanofi, 5,Alcon Research Institute, 2; R. Colbert, None.

To cite this abstract in AMA style:

Gill T, Brooks SR, Asquith M, Rosenbaum JT, Colbert R. Inter-Omic Analysis Reveals Functional Relationship between Diverse Gut Microbiota and Dysregulated Host Immune Response in HLA-B27-Mediated Experimental Spondyloarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/inter-omic-analysis-reveals-functional-relationship-between-diverse-gut-microbiota-and-dysregulated-host-immune-response-in-hla-b27-mediated-experimental-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inter-omic-analysis-reveals-functional-relationship-between-diverse-gut-microbiota-and-dysregulated-host-immune-response-in-hla-b27-mediated-experimental-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology